PPD ACT is a research study developed by Postpartum Depression: Action Towards Causes and Treatment (PACT) Consortium, an international group of academic clinicians and scientists committed to understanding the interaction of genes and environment to predict which women are at risk of postpartum depression (PPD).
We are working together to engage women who currently have or had postpartum depression or postpartum psychosis in a genetics research study using our free iOS and free android mobile app, PPD ACT, which is currently available in Australia, Canada, and the US, and coming soon to the UK and to Denmark.
The PACT Australia team is composed of several different institutions, including Naomi Wray and team at Queensland.
The Australian arm of the PPD ACT study is designed to collect more detailed information about health and lifestyle as part of our "Genetics of Risk and Response to Treatment of Depression" study. You can find more information on the study website.
The PACT Canada team is comprised of contributors from institutions across Canada, and is being led by Dr. Simone Vigod and her team from Women's College Hospital at the University of Toronto, in Toronto, Ontario. PACT Canada gratefully acknowledges funding from the Women's Mental Health Program at Women's College Hospital for the launch of the PACT Canada pilot study of the PACT app.
The PACT Canada team also gratefully acknowledges the research personnel supporting the development of this project, including Ms. Neesha Hussain-Shamsy and Dr. Kennedy's Research Team at the Psychiatric Neurogenetics Laboratory and Tanenbaum Centre for Pharmacogenetics at the Centre for Addiction and Mental Health.
The PACT UK team is associated with National Centre for Mental Health and Cardiff University.
The PACT Denmark team is associated with National Center for Register-Based Research, Aarhus University.